EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark VISCOFAN FIBERCOLL-FLEX was filed as Word mark on 07/21/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/15/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018736010 |
| Application date | July 21, 2022 |
| Publication date | September 7, 2022 |
| Entry date | December 15, 2022 |
| Expiration date | July 21, 2032 |
Trademark owner
C/ Berroa nº 15 4ª pl. Polígono Industrial Berroa
31192 TAJONAR (NAVARRA)
ES
31192 TAJONAR (NAVARRA)
ES
Trademark representatives
Edificio Aqua C/ Agustín de Foxá nº 4 - 10
28036 Madrid
ES
goods and services
1
Biological materials or preparations for 3D printers, hydrogels for cell culture; Hydrogels for cell growth; Cell growth media Other than for medical or veterinary use; Nutritional agents for processing live cells, for non-medical use; Culture media for microbiology; Reagents for scientific and medical research; Synthetic peptides, Not for pharmaceutical purposes; Synthetic peptide derivatives (not for pharmaceutical purposes); Cells, for non-medical use, not for veterinary use or not for pharmaceutical use; Cells or tissues in hydrogels, for non-medical use, not for veterinary use or not for pharmaceutical use; Biologically compatible polymers, namely Hydrogels used for producing polymeric networks for use in the manufacture of engineered living tissues for medical, scientific and non-scientific purposes; Cell culture medium for use in the biotechnology industry; Media for cell culture for use in non-medical research laboratories; Biological preparations for use in cell cultures, for non-medical purposes and for non-veterinary purposes; Live engineered tissues and tissue assemblies, namely human and animal organs, connective tissue, epithelial tissue, muscle tissue and nervous tissue, including tissue assemblies, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Protein in raw material form for scientific and medical research
2
Organic inks for printers; Organic inks for 3D printers
5
Hydrogels for cell biology applications for medical use, For veterinary use and for pharmaceutical; Hydrogels for cell growth, cell growth and transplantation, cell-based trials, cancer cell research, regenerative medicine, stem cell growth and drug delivery; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes; Hydrogels for cell growth for medical use, For veterinary use and for pharmaceutical; Cell culture media; Nutritional agents for processing live cells; synthetic peptides; Synthetic peptide derivatives; cells for medical, pharmaceutical and veterinary uses; Cells or tissues in hydrogels For medicinal purposes, For veterinary use or for pharmaceutical purposes; Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Pharmaceutical cellulose nanofibre-based preparations for use in 3D bioprinting of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implantation of living tissue with controlled tissue regeneration; Implants containing living tissue; Implantable living tissues for use in guided tissue regeneration; Skin grafts; Surgical implants made of living tissue; Surgical implants of living tissue derived from stem cells; Transdermal patches for use in creating skin for prosthetics and skin grafts; Living tissue for transplantation; Engineered biological tissues and organs, namely, Human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular and nervous tissue and organs, for medical use; Biological molecules to aid tissue engineering; Haemostatic gel matrix preparations for treating wounds; Natural biomaterial for bone, blood and tissue growth for medical purposes; Pharmaceuticals for tissue regeneration, for tissue repair and treatment, whether human or animal; Pharmaceutical preparations for treating diseases relating to bones, cartilages, blood vessels, degeneration of nerve cells, degeneration of tendons and ligaments, degeneration of the retina, degeneration of the kidneys; Soft tissue degeneration, diseases involving abnormal cell growth; Natural biomaterial for bone grafting; Natural biomaterial for grafting cartilage; Biological tissue cultures for medical purposes; biologicaltissue cultures for medical purposes; biological tissue grafts; Biological bone and skin tissue impregnated with oxygen lines, enabling the relevant tissue structures to increase cell survival in tissue intended for subsequent implant; Gene therapy preparations, namely, Genetically modified tissue for transplantation; Implantable stents comprising living tissue for maintaining tissue structure; Natural biomaterial for bone and tissue growth, for medical use
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 16, 2024 | Change Representative, Published | ||
| January 15, 2024 | Change Representative, Published |
ID: 11018736010